Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fischer

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Internal Medicine|May 23, 2026
Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestionJuliana Giorgi, Salomon Chamay, Caroline O Fischer-Bacca, et al.
Plos One|March 29, 2014
Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platformNicholas O Fischer, Dina R Weilhammer, Alexis Dunkle, et al.
Frontiers in Cellular Neuroscience|December 25, 2023
Corrigendum: Spatiotemporal analysis of 3D human iPSC-derived neural networks using a 3D multi-electrode arrayDoris Lam, Heather A Enright, Jose Cadena, et al.
Frontiers in Cellular Neuroscience|November 29, 2023
Spatiotemporal analysis of 3D human iPSC-derived neural networks using a 3D multi-electrode arrayDoris Lam, Heather A Enright, Jose Cadena, et al.
Biomaterials|October 1, 2013
The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challengeDina R Weilhammer, Craig D Blanchette, Nicholas O Fischer, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine DevelopmentSean F Gilmore, Wei He, Angela C Evans, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 1, 2026
GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-AnalysisPedro Gomes Batista, Railla Raquel Albino Dos Santos Silva, Marcela Vasconcelos Montenegro, et al.
Journal of the American Chemical Society|May 20, 2009
Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particlesSarah E Baker, Robert C Hopkins, Craig D Blanchette, et al.
Scientific Reports|July 5, 2020
Functional and transcriptional characterization of complex neuronal co-culturesHeather A Enright, Doris Lam, Aimy Sebastian, et al.
Vaccines|November 26, 2024
Cell-Free Screening, Production and Animal Testing of a STI-Related Chlamydial Major Outer Membrane Protein Supported in NanolipoproteinsMariam Mohagheghi, Abisola Abisoye-Ogunniyan, Angela C Evans, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Internal Medicine|May 23, 2026
Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestionJuliana Giorgi, Salomon Chamay, Caroline O Fischer-Bacca, et al.
Plos One|March 29, 2014
Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platformNicholas O Fischer, Dina R Weilhammer, Alexis Dunkle, et al.
Frontiers in Cellular Neuroscience|December 25, 2023
Corrigendum: Spatiotemporal analysis of 3D human iPSC-derived neural networks using a 3D multi-electrode arrayDoris Lam, Heather A Enright, Jose Cadena, et al.
Frontiers in Cellular Neuroscience|November 29, 2023
Spatiotemporal analysis of 3D human iPSC-derived neural networks using a 3D multi-electrode arrayDoris Lam, Heather A Enright, Jose Cadena, et al.
Biomaterials|October 1, 2013
The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challengeDina R Weilhammer, Craig D Blanchette, Nicholas O Fischer, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine DevelopmentSean F Gilmore, Wei He, Angela C Evans, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 1, 2026
GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-AnalysisPedro Gomes Batista, Railla Raquel Albino Dos Santos Silva, Marcela Vasconcelos Montenegro, et al.
Journal of the American Chemical Society|May 20, 2009
Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particlesSarah E Baker, Robert C Hopkins, Craig D Blanchette, et al.
Scientific Reports|July 5, 2020
Functional and transcriptional characterization of complex neuronal co-culturesHeather A Enright, Doris Lam, Aimy Sebastian, et al.
Vaccines|November 26, 2024
Cell-Free Screening, Production and Animal Testing of a STI-Related Chlamydial Major Outer Membrane Protein Supported in NanolipoproteinsMariam Mohagheghi, Abisola Abisoye-Ogunniyan, Angela C Evans, et al.
Pageof 15